21-43066294-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 7P and 4B. PM1PP2PP3_StrongBS2

The NM_000071.3(CBS):​c.400G>A​(p.Gly134Arg) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G134A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000081 ( 2 hom., cov: 14)
Exomes 𝑓: 0.000094 ( 13 hom. )

Consequence

CBS
NM_000071.3 missense

Scores

10
7
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 6.84

Publications

3 publications found
Variant links:
Genes affected
CBS (HGNC:1550): (cystathionine beta-synthase) The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016]
CBS Gene-Disease associations (from GenCC):
  • classic homocystinuria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, PanelApp Australia, ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 12 uncertain in NM_000071.3
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 107 curated pathogenic missense variants (we use a threshold of 10). The gene has 4 curated benign missense variants. Gene score misZ: 0.8318 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to classic homocystinuria.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.957
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CBSNM_000071.3 linkc.400G>A p.Gly134Arg missense_variant Exon 5 of 17 ENST00000398165.8 NP_000062.1 P35520-1Q9NTF0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CBSENST00000398165.8 linkc.400G>A p.Gly134Arg missense_variant Exon 5 of 17 1 NM_000071.3 ENSP00000381231.4 P35520-1

Frequencies

GnomAD3 genomes
AF:
0.0000911
AC:
9
AN:
98808
Hom.:
2
Cov.:
14
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000676
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000120
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000997
AC:
25
AN:
250778
AF XY:
0.0000737
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000708
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000881
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000943
AC:
93
AN:
986700
Hom.:
13
Cov.:
15
AF XY:
0.0000933
AC XY:
47
AN XY:
503732
show subpopulations
African (AFR)
AF:
0.000305
AC:
5
AN:
16396
American (AMR)
AF:
0.000143
AC:
6
AN:
42030
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20706
East Asian (EAS)
AF:
0.000840
AC:
32
AN:
38078
South Asian (SAS)
AF:
0.00
AC:
0
AN:
72002
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37442
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3802
European-Non Finnish (NFE)
AF:
0.0000660
AC:
47
AN:
712598
Other (OTH)
AF:
0.0000687
AC:
3
AN:
43646
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000809
AC:
8
AN:
98848
Hom.:
2
Cov.:
14
AF XY:
0.0000627
AC XY:
3
AN XY:
47880
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
17138
American (AMR)
AF:
0.00
AC:
0
AN:
11410
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2574
East Asian (EAS)
AF:
0.000452
AC:
2
AN:
4422
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3212
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7792
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
186
European-Non Finnish (NFE)
AF:
0.000120
AC:
6
AN:
50070
Other (OTH)
AF:
0.00
AC:
0
AN:
1356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.565
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000125
Hom.:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000123
AC:
15
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
May 30, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.G134R variant (also known as c.400G>A), located in coding exon 3 of the CBS gene, results from a G to A substitution at nucleotide position 400. The glycine at codon 134 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -

Classic homocystinuria Uncertain:1
Sep 16, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Uncertain:1
Jun 05, 2018
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The G134R variant of uncertain significance in the CBS gene has been identified in the CBS gene has not been published as pathogenic or been reported as benign to our knowledge. This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The G134R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Nevertheless, this variant lacks observation in a significant number of affected individuals, segregation data, and functional evidence, which would further clarify its pathogenicity. Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. -

HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED Uncertain:1
Aug 11, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 134 of the CBS protein (p.Gly134Arg). This variant is present in population databases (rs147474549, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with CBS-related conditions. ClinVar contains an entry for this variant (Variation ID: 212879). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Pathogenic
0.45
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.99
D;D;D;D;.
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Pathogenic
0.99
.;.;.;D;D
M_CAP
Pathogenic
0.92
D
MetaRNN
Pathogenic
0.96
D;D;D;D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.0
H;H;H;H;.
PhyloP100
6.8
PrimateAI
Uncertain
0.65
T
PROVEAN
Pathogenic
-8.0
D;D;D;D;D
REVEL
Pathogenic
0.86
Sift
Uncertain
0.013
D;D;D;D;D
Sift4G
Uncertain
0.023
D;D;D;D;D
Polyphen
1.0
D;D;D;D;.
Vest4
0.89
MutPred
0.84
Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);
MVP
0.92
MPC
1.2
ClinPred
0.97
D
GERP RS
5.2
Varity_R
0.74
gMVP
0.93
Mutation Taster
=27/73
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147474549; hg19: chr21-44486404; API